ইঙ্গিত ও ব্যবহার
Suxamet এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Suxamethonium Chloride is usually given by bolus intravenous or intramuscular injection. Adults: The dose of Suxamethonium depends on body weight, the degree of muscle relaxation required, the route of administration, and how the individual patient responds. To achieve endotracheal intubation, Suxamethonium is usually given intravenously at a dose of 1 mg/kg. This dose usually produces muscle relaxation within about 30 to 60 seconds and lasts about 2 to 6 minutes. Supplementary doses of 50% to 100% of the initial dose, given at intervals of 5 to 10 minutes, will maintain muscle relaxation during short surgical procedures performed under general anesthesia. For prolonged surgical procedures, Suxamethonium may instead be given by intravenous infusion as a 0.1% to 0.2% solution, diluted in 5% glucose solution or sterile isotonic saline solution, at a rate of 2.5 to 4 mg per minute. The infusion rate should be adjusted according to how the individual patient responds. The total dose given by repeated intravenous injection or continuous infusion should not exceed 500 mg per hour. Children: Infants and young children are more resistant to Suxamethonium than adults. The recommended intravenous dose for infants is 2 mg/kg. A dose of 1 mg/kg is recommended for older children. When given as an intravenous infusion in children, the dosage follows the adult regimen, with a proportionately lower initial infusion rate based on body weight. Suxamethonium may be given intramuscularly to infants at doses of up to 4 to 5 mg/kg, and to older children at doses of up to 4 mg/kg. These doses produce muscle relaxation within about 3 minutes. A total dose of 150 mg should not be exceeded.
পার্শ্বপ্রতিক্রিয়া
Cardiovascular effects can include a slower or faster heart rate, high or low blood pressure, and irregular heart rhythms. Breathing-related effects may include bronchospasm and prolonged breathing difficulty or apnea. Muscle-related effects can include muscle twitching, post-operative muscle aches, and myoglobinemia. Other effects may include high body temperature, increased pressure in the eyes or stomach, skin rash, and excessive salivation.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
Suxonium should be given only by, or under the close supervision of, an anesthetist who is familiar with its actions, characteristics, and hazards, and who is skilled in managing artificial respiration. It should be used only where facilities for immediate endotracheal intubation and oxygen delivery by intermittent positive pressure ventilation are readily available. Elderly patients may be more prone to cardiac arrhythmias, particularly when digitalis-like drugs are being taken concurrently.
নিষেধাজ্ঞা
Suxamethonium has no effect on the level of consciousness and should not be administered to a patient who is notfullyanesthetized. Suxamethonium should not be administered to patients known to be hypersensitive to the drug. Suxamethonium is contraindicated in patients known to have an inherited atypical plasma cholinesterase activity. An acute transient rise in serum potassium often occurs following the administration of Suxamethonium in normal individuals (usually 0.5 mmol/Litre). But in certain pathological states it may cause excessive increase in serum potassium leading to serious cardiac arrhythmias and cardiac arrest. For this reason, use of Suxamethonium is contraindicated in patients recovering from major trauma, patients recovering from severe burns, patients with neurological deficits involving acute major muscle wasting and patients with pre-existing hyperkalemia. Suxamethonium causes a slight transient rise in intra-ocular pressure, and should therefore not be used in the presence of open eye injuries. The injection is contraindicated in new-born infants, especially in immature neonates.